Hollsteen
← Zscaler

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2017: $8.0M · 10-Q 0001713683-18-000007 filed Jun 7, 2018Research and development · Q4 FY2017: $9.0M · derived · 10-K 0001628280-18-011833 filed Sep 13, 2018Research and development · Q1 FY2018: $9.0M · 10-Q 0001713683-18-000009 filed Dec 6, 2018Research and development · Q2 FY2018: $9.0M · 10-Q 0001713683-19-000006 filed Mar 6, 2019Research and development · Q3 FY2018: $10.0M · 10-Q 0001713683-18-000007 filed Jun 7, 2018Research and development · Q4 FY2018: $11.0M · derived · 10-K 0001713683-19-000030 filed Sep 18, 2019Research and development · Q1 FY2019: $13.0M · 10-Q 0001713683-18-000009 filed Dec 6, 2018Research and development · Q2 FY2019: $15.0M · 10-Q 0001713683-19-000006 filed Mar 6, 2019Research and development · Q3 FY2019: $16.0M · 10-Q 0001713683-19-000016 filed Jun 5, 2019Research and development · Q4 FY2019: $17.0M · derived · 10-K 0001713683-20-000163 filed Sep 17, 2020Research and development · Q1 FY2020: $20.0M · 10-Q 0001713683-19-000053 filed Dec 6, 2019Research and development · Q2 FY2020: $21.0M · 10-Q 0001713683-20-000037 filed Mar 4, 2020Research and development · Q3 FY2020: $24.0M · 10-Q 0001713683-20-000095 filed Jun 3, 2020Research and development · Q4 FY2020: $33.0M · derived · 10-K 0001713683-21-000175 filed Sep 16, 2021Research and development · Q1 FY2021: $36.0M · 10-Q 0001713683-20-000193 filed Dec 8, 2020Research and development · Q2 FY2021: $42.0M · 10-Q 0001713683-21-000037 filed Mar 4, 2021Research and development · Q3 FY2021: $41.0M · 10-Q 0001713683-21-000096 filed Jun 3, 2021Research and development · Q4 FY2021: $56.0M · derived · 10-K 0001713683-22-000081 filed Sep 15, 2022Research and development · Q1 FY2022: $65.0M · 10-Q 0001713683-21-000238 filed Dec 8, 2021Research and development · Q2 FY2022: $69.0M · 10-Q 0001713683-22-000029 filed Mar 9, 2022Research and development · Q3 FY2022: $77.0M · 10-Q 0001713683-22-000056 filed Jun 9, 2022Research and development · Q4 FY2022: $78.0M · derived · 10-K 0001713683-23-000113 filed Sep 14, 2023Research and development · Q1 FY2023: $75.0M · 10-Q 0001713683-22-000123 filed Dec 7, 2022Research and development · Q2 FY2023: $86.0M · 10-Q 0001713683-23-000030 filed Mar 8, 2023Research and development · Q3 FY2023: $93.0M · 10-Q 0001713683-23-000059 filed Jun 7, 2023Research and development · Q4 FY2023: $96.0M · derived · 10-K 0001713683-24-000109 filed Sep 12, 2024Research and development · Q1 FY2024: $114M · 10-Q 0001713683-23-000171 filed Dec 6, 2023Research and development · Q2 FY2024: $122M · 10-Q 0001713683-24-000041 filed Mar 6, 2024Research and development · Q3 FY2024: $125M · 10-Q 0001713683-24-000075 filed Jun 7, 2024Research and development · Q4 FY2024: $139M · derived · 10-K 0001713683-25-000158 filed Sep 11, 2025Research and development · Q1 FY2025: $154M · 10-Q 0001713683-24-000150 filed Dec 5, 2024Research and development · Q2 FY2025: $171M · 10-Q 0001713683-25-000033 filed Mar 10, 2025Research and development · Q3 FY2025: $170M · 10-Q 0001713683-25-000079 filed May 29, 2025Research and development · Q4 FY2025: $178M · derived · 10-K 0001713683-26-000157 filed Sep 3, 2026Research and development · Q1 FY2026: $200M · 10-Q 0001713683-25-000205 filed Nov 25, 2025Research and development · Q2 FY2026: $229M · 10-Q 0001713683-26-000048 filed Feb 26, 2026Research and development · Q3 FY2026: $232M · 10-Q 0001713683-26-000096 filed May 26, 2026Research and development · Q4 FY2026: $241M · derived · 10-K 0001713683-26-000157 filed Sep 3, 2026missing17a241a8Q1 FY2016Q4 FY2026Q4 FY2019
$MResearch and development · Q4 FY2018: $11.0M · derived · 10-K 0001713683-19-000030 filed Sep 18, 2019Research and development · Q1 FY2019: $13.0M · 10-Q 0001713683-18-000009 filed Dec 6, 2018Research and development · Q2 FY2019: $15.0M · 10-Q 0001713683-19-000006 filed Mar 6, 2019Research and development · Q3 FY2019: $16.0M · 10-Q 0001713683-19-000016 filed Jun 5, 2019Research and development · Q4 FY2019: $17.0M · derived · 10-K 0001713683-20-000163 filed Sep 17, 2020Research and development · Q1 FY2020: $20.0M · 10-Q 0001713683-19-000053 filed Dec 6, 2019Research and development · Q2 FY2020: $21.0M · 10-Q 0001713683-20-000037 filed Mar 4, 2020Research and development · Q3 FY2020: $24.0M · 10-Q 0001713683-20-000095 filed Jun 3, 202017a2411aQ4 FY2018Q3 FY2020Q4 FY2019
Q4 FY2019
17a$M
derived
All values (38)
PeriodValue ($M)Status
Q4 FY2026241derived
Q3 FY2026232reported
Q2 FY2026229reported
Q1 FY2026200reported
Q4 FY2025178derived
Q3 FY2025170reported
Q2 FY2025171reported
Q1 FY2025154reported
Q4 FY2024139derived
Q3 FY2024125reported
Q2 FY2024122reported
Q1 FY2024114reported
Q4 FY202396derived
Q3 FY202393reported
Q2 FY202386reported
Q1 FY202375reported
Q4 FY202278derived
Q3 FY202277reported
Q2 FY202269reported
Q1 FY202265reported
Q4 FY202156derived
Q3 FY202141reported
Q2 FY202142reported
Q1 FY202136reported
Q4 FY202033derived
Q3 FY202024reported
Q2 FY202021reported
Q1 FY202020reported
Q4 FY201917derived
Q3 FY201916reported
Q2 FY201915reported
Q1 FY201913reported
Q4 FY201811derived
Q3 FY201810reported
Q2 FY20189reported
Q1 FY20189reported
Q4 FY20179derived
Q3 FY20178reported
Q1 FY2016 – Q2 FY2017–missing (6 periods): No verified SEC value extracted, although the company reports this metric in other periods.

Show reported periods only · CSV with all sources · Technical ID: rnd

More metrics for Zscaler

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$17.0M (derived)
Period
Q4 FY2019, ended Jul 31, 2019 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 62M − 45M = $17.0M (FY value from 10-K 0001713683-20-000163; 9-month value from the Q3-10-Q)
Source
10-K, filed Sep 17, 2020 · 0001713683-20-000163
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$17.0MSep 17, 202010-K 0001713683-20-000163derived · confidence 1. · current